新华财经北京11月7日电新华财经和面包财经研究员梳理的公开资料显示，2025年10月港股共有94家上市公司发起回购，累计回购5.25亿股，回购金额合计 达93.72亿港元，较去年同期的92.71亿港元上升1.09%。 其中，小米集团-W、中国飞鹤、康宁杰瑞制药-B等公司于10月首度进行年内回购或明显加大回购力度。 行业方面，2025年10月发起回购的港股上市公司主要分布在软件服务、其他医疗保健等行业。 港股上市公司10月回购总额93.72亿港元 根据信披数据，2025年10月港股共有94家上市公司发起回购，累计回购5.25亿股，回购金额合计达93.72亿港元，较去年同期的92.71亿港元上升1.09%。 从个股来看，腾讯控股、汇丰控股及小米集团-W的10月回购金额居于前列。此外，中国飞鹤、康宁杰瑞制药-B等公司于10月首度进行年内回购或明显加大 回购力度。 小米集团-W 10月回购金额为12.84亿港元，回购数量为2677万股，回购最低价为45.9港元／股，最高价为53.25港元／股。公司于10月明显加大回购力度。 2025年前10月，小米集团-W合计回购15.37亿港元。 中国飞鹤同样于10月加大回购力度， ...

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6]. Core Insights - The company reported a strong revenue growth of 33.1% year-on-year, achieving $161 million in revenue for H1 2025, with a net profit of $14.64 million, reflecting a significant increase of 364.25% [1]. - The domestic market showed stable development with a revenue of $89.68 million, a growth of 1.25%, while overseas revenue reached $71.67 million, marking a substantial increase of 124.51% [2]. - The total number of invisible orthodontic cases reached 225,800, a year-on-year growth of 47.7%, with overseas cases growing by 103.5% [3]. - The company has launched innovative products and solutions, including the first-of-its-kind anti-caries invisible orthodontic appliance, enhancing clinical value and expanding its global supply chain [4]. - Digital upgrades have improved clinical diagnosis and treatment, integrating tools for real-time treatment monitoring and communication with patients [5]. Summary by Sections Financial Performance - In H1 2025, the company achieved a revenue of $161 million, a 33.1% increase year-on-year, and a net profit of $14.64 million, up 364.25% [1]. - Operating cash flow was $17.53 million, reflecting a growth of 196.72% [1]. Market Development - Domestic revenue was $89.68 million, growing 1.25%, while overseas revenue was $71.67 million, increasing by 124.51% [2]. - The company has strategically positioned itself in early treatment and lower-tier markets in China, driving stable growth [2]. Business Growth - The total number of invisible orthodontic cases reached 225,800, with domestic cases at approximately 108,600 (up 14.0%) and overseas cases at about 117,200 (up 103.5%) [3]. - Revenue from invisible orthodontic solutions was $86.23 million, a 2.22% increase, while sales of invisible orthodontic appliances reached $70.99 million, up 122.3% [3]. Innovation and Expansion - The company has focused on technological innovation, launching several new products and solutions to meet clinical needs [4]. - A more resilient and diversified global supply chain is being established to support rapid business expansion [4]. Digital Transformation - The integration of smart initial diagnosis communication and real-time treatment monitoring tools has enhanced the clinical experience for both doctors and patients [5].